A new drug-releasing system, TAR-200, eliminated tumours in 82% of patients in a phase 2 clinical trial for individuals with high-risk...

A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a key...

A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a key...

PARIRENYATWA Radiotherapy Centre is once again a hub of life-saving cancer care, offering chemotherapy, brachytherapy for gynaecological cancers, and...

A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...

A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...

A new study may offer a breakthrough for patients with advanced melanoma who don’t respond to current immunotherapy treatments. The research,...

A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to...

NRG Oncology recently reported the results of the National Cancer Institute-sponsored phase II/III NRG-BN007 clinical trial showing that combining...

A $40,000 dialysis machine donated to Labasa Hospital’s Dialysis Centre is set to expand life-saving treatment for kidney patients in Vanua Levu....